TRIO Pharmaceuticals, Inc. is a cancer immunotherapeutics company pioneering dual action drugs to generate immunogenic tumors. TRIO's innovative antibody drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways.
Employees: 1-10
Founded date: 2018
Investors 2
| Date | Name | Website |
| 03.12.2022 | SeedFolio | seedfolio.... |
| 12.08.2021 | MBC BioLab... | mbcbiolabs... |
Mentions in press and media 1
| Date | Title | Description | Source |
| - | Trio Pharmaceuticals | “TRIO Pharmaceuticals, Inc.” | fastfounde... |